John D Chisholm

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where John D Chisholm is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Active
8 Finished

Targeting the Serine/Threonine-protein Phosphatase-5 in Kidney Cancer
Chisholm, J. D.
Department of Defense, Research Foundation of State University of New York
9/30/20 → 9/29/21
Project: Research project
Defining the Molecular Architecture for Transmembrane Acylation by a Membrane Bound O-Acyltransferase
Hougland, J. L., Nangia, S. & Chisholm, J. D.
National Institutes of Health/DHHS
9/1/19 → 8/31/22
Project: Research project
Defining the Molecular Architecture for Transmembrane Acylation by a Membrane Bound O-Acyltransferase
Hougland, J. L. & Chisholm, J. D.
National Institutes of Health/DHHS
9/1/19 → 8/31/22
Project: Research project
Novel and Potent SHIP1 Inhibitors for Improving Hematologic Recovery Following Myelosuppressive Therapies
Chisholm, J. D.
National Institutes of Health/DHHS, Alterna Therapeutics
6/10/19 → 5/31/20
Project: Research project
Translating SHIP1 Genetics to Generate a Novel Alzheimer’s Pharmacologic Agent
Chisholm, J. D.
National Institute on Aging/NIH/DHHS, University of Kentucky
9/15/18 → 6/30/19
Project: Research project

1387 Citations
22 h-Index
49 Article
4 Review article
4 Patent
1 Letter

Targeting SHIP1 and SHIP2 in cancer
Pedicone, C., Meyer, S. T., Chisholm, J. D. & Kerr, W. G., Feb 2 2021, In: Cancers. 13, 4, p. 1-24 24 p., 890.
Research output: Contribution to journal › Review article › peer-review

Open Access
An overview of ghrelin O-acyltransferase inhibitors: a literature and patent review for 2010-2019
Moose, J. E., Leets, K. A., Mate, N. A., Chisholm, J. D. & Hougland, J. L., Aug 2 2020, In: Expert opinion on therapeutic patents. 30, 8, p. 581-593 13 p.
Research output: Contribution to journal › Review article › peer-review
1 Scopus citations
Pan-SHIP1/2 inhibitors promote microglia effector functions essential for CNS homeostasis
Pedicone, C., Fernandes, S., Dungan, O. M., Dormann, S. M., Viernes, D. R., Adhikari, A. A., Choi, L. B., De Jong, E. P., Chisholm, J. D. & Kerr, W. G., Mar 2020, In: Journal of cell science. 133, 5, jcs238030.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Scopus citations
Small molecule targeting of SHIP1 and SHIP2
Kerr, W. G., Pedicone, C., Dormann, S., Pacherille, A. & Chisholm, J. D., 2020, In: Biochemical Society transactions. 48, 1, p. 291-300 10 p.
Research output: Contribution to journal › Review article › peer-review
4 Scopus citations
Dialkylation of indoles with trichloroacetimidates to access 3,3-disubstituted indolenines
Suzuki, T., Mate, N. A., Adhikari, A. A. & Chisholm, J. D., 2019, In: Molecules. 24, 22, 4143.
Research output: Contribution to journal › Article › peer-review

Open Access

Today's Events In Washington
John D Chisholm
3/24/21
1 item of Media coverage
Press/Media: Expert Comment
Australia Patent: The Research Foundation for The State University of New York, Chiara Pedicone, John D. Chisholm, Syracuse University, Shawn Domann, William Kerr File Application for 'Methods of activating microglial cells'
John D Chisholm
3/19/21
1 item of Media coverage
Press/Media: Expert Comment
The College Welcomed New Faculty in 2020
John D Chisholm
12/23/20
1 item of Media coverage
Press/Media: Expert Comment
Entrepreneurship Is Accelerating at the Fastest Rate in Decades During This Pandemic
John D Chisholm
11/20/20
1 item of Media coverage
Press/Media: Expert Comment
Back in the News: Judge Rules Against Marsy’s Law
John D Chisholm
11/4/20
2 items of Media coverage
Press/Media: Expert Comment